Literature DB >> 3413728

Two antiplatelet agents from Magnolia officinalis.

C M Teng1, C C Chen, F N Ko, L G Lee, T F Huang, Y P Chen, H Y Hsu.   

Abstract

Magnolol and honokiol are two position isomers isolated from the bark of Magnolia officinalis. Both inhibited the aggregation and ATP release of rabbit platelet-rich plasma induced by collagen and arachidonic acid without affecting that induced by ADP, PAF or thrombin. Aggregation of washed platelets was more markedly inhibited than that of platelet-rich plasma, while the aggregation of whole blood was least affected by both inhibitors. Thromboxane B2 formation caused by collagen, arachidonic acid or thrombin was in each case inhibited by magnolol and honokiol. The rise of intracellular calcium caused by arachidonic acid or collagen was also suppressed by both agents. Collagen-induced intracellular calcium increase in the presence of indomethacin was suppressed by magnolol. It is concluded that the antiplatelet effect of magnolol and honokiol is due to an inhibitory effect on thromboxane formation and also an inhibition of intracellular calcium mobilization.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3413728     DOI: 10.1016/0049-3848(88)90336-2

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  34 in total

1.  Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects.

Authors:  Zhiyun He; Dharmalingam Subramaniam; Satish Ramalingam; Animesh Dhar; Russell G Postier; Shahid Umar; Youcheng Zhang; Shrikant Anant
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-08-11       Impact factor: 4.052

2.  Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells.

Authors:  Sivapriya Ponnurangam; Joshua M V Mammen; Satish Ramalingam; Zhiyun He; Youcheng Zhang; Shahid Umar; Dharmalingam Subramaniam; Shrikant Anant
Journal:  Mol Cancer Ther       Date:  2012-02-08       Impact factor: 6.261

3.  In vitro growth inhibition of human cancer cells by novel honokiol analogs.

Authors:  Jyh Ming Lin; A S Prakasha Gowda; Arun K Sharma; Shantu Amin
Journal:  Bioorg Med Chem       Date:  2012-04-03       Impact factor: 3.641

4.  Honokiol promotes non-rapid eye movement sleep via the benzodiazepine site of the GABA(A) receptor in mice.

Authors:  Wei-Min Qu; Xiao-Fang Yue; Yu Sun; Kun Fan; Chang-Rui Chen; Yi-Ping Hou; Yoshihiro Urade; Zhi-Li Huang
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

5.  Facile purification of honokiol and its antiviral and cytotoxic properties.

Authors:  Franck Amblard; David Delinsky; Jack L Arbiser; Raymond F Schinazi
Journal:  J Med Chem       Date:  2006-06-01       Impact factor: 7.446

6.  Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol.

Authors:  Franck Amblard; Baskaran Govindarajan; Benjamin Lefkove; Kimberly L Rapp; Mervi Detorio; Jack L Arbiser; Raymond F Schinazi
Journal:  Bioorg Med Chem Lett       Date:  2007-06-10       Impact factor: 2.823

7.  Stimulation of the BK(Ca) channel in cultured smooth muscle cells of human trachea by magnolol.

Authors:  S-N Wu; C-C Chen; H-F Li; Y-K Lo; S-A Chen; H-T Chiang
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

8.  Self-assembled hydrophobic honokiol loaded MPEG-PCL diblock copolymer micelles.

Authors:  MaLing Gou; XiuLing Zheng; Ke Men; Juan Zhang; BiLan Wang; Lei Lv; XiuHong Wang; YinLan Zhao; Feng Luo; LiJuan Chen; Xia Zhao; YuQuan Wei; ZhiYong Qian
Journal:  Pharm Res       Date:  2009-07-01       Impact factor: 4.200

9.  Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO.

Authors:  Tao Wang; Fei Chen; Zhe Chen; Yi-Feng Wu; Xiao-Li Xu; Shu Zheng; Xun Hu
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

10.  Anti-inflammatory and analgesic effects of magnolol.

Authors:  J P Wang; M F Hsu; S L Raung; C C Chen; J S Kuo; C M Teng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-12       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.